Bounded Hyperbaric oxygen HBOT signal: cited direct receipts are heterogeneous

Selected angle: source

One-sentence thesis

The cited direct receipts support a heterogeneous working map, not one uniform effect estimate across the bundle.

Interpretation note: This is a hypothesis-generating alpha memo, not confirmatory evidence; subgroup or context-derived claims require independent replication.

Why this is surprising

The surprise is the bounded heterogeneity: the cited direct receipts do not support one uniform effect estimate, so the useful alpha is the specific receipt map and its unresolved spread.

Evidence Landscape

Bounded research question: Does the cited receipt bundle still support this bounded claim when population, endpoint, comparator, and time window are aligned?

Evidence receipts

• fact_id=144916 (A_core) — HBOT was significantly effective in complete healing of diabetic foot ulcer (OR = 0.29; 95% CI 0.14-0.61; I2 = 62%) doi=10.1038/s41598-021-81886-1
• fact_id=187957 (A_core) — Two studies found no difference in major amputation rate, whereas one large retrospective study found 2% more major amputations in the hyperbaric oxygen group. doi=10.1111/wrr.12776
• fact_id=190396 (A_core) — a higher incidence of complete healing was noted with group B (20%) than with group A (4.5%) and group C (3.8%). doi=10.1111/wrr.12853
• fact_id=188542 (A_core) — T-cytotoxic senescent cell percentages decreased significantly by -10.96%±12.59 (p=0.0004) post-HBOT. doi=10.18632/aging.202188
• fact_id=187991 (A_core) — HBOT increased the total efficacy rate (TEF) (OR = 4.84, 95% CI = 3.19-7.33, P < 0.00001) doi=10.3389/fnagi.2019.00086

What this changes

Treat this as a focused working signal, not a broad topic claim. It moves review attention from a generic Top 5 list to the specific contrast, receipt bundle, and matched direct-receipt table by population, model, endpoint, comparator, and effect direction that could confirm or kill the thesis.

Limitations

• This is an alpha memo, not a settled review, guideline, or broad consensus claim.
• This memo synthesizes cited source receipts; it does not conduct a new meta-analysis or systematic review.
• Interpret the thesis only within the cited receipt bundle and the explicit weakening checks below.
• Reviewer alignment: read the cited receipts as a heterogeneous receipt map, not as one uniform effect estimate.
• Independent receipts fail to reproduce the claimed contrast.
• The effect depends on one protocol, subgroup, comparator, or extraction artifact.

What would weaken this

• Independent receipts fail to reproduce the claimed contrast.
• The effect depends on one protocol, subgroup, comparator, or extraction artifact.

Strongest counter-evidence

• fact_id=187957 (A_core) — Two studies found no difference in major amputation rate, whereas one large retrospective study found 2% more major amputations in the hyperbaric oxygen group. Source: Hyperbaric oxygen therapy for nonischemic diabetic ulcers: A systematic review

Next extraction

• Extract independent A_core/B_context receipts that test the lead contrast directly.
• Audit whether each direct receipt remains comparable on population, endpoint, comparator, and measurement method.

Subtopic recommendations

• This topic looks broad/noisy enough that the next run should split it before trying to force one public thesis.
• without_conventional_over — Potential markers of healing from near infrared spectroscopy imaging of venous leg ulcer. A randomized controlled clinical trial comparing conventional with hyperbaric oxygen treat
• conventional_without_mortality — Necrotising Soft Tissue Infections: The Effect of Hyperbaric Oxygen on Mortality
• adjunctive_standard_without — The role of hyperbaric oxygen therapy in treating extensive Fournier's gangrene
• conventional_without_carboxyhemoglobin — Acute carbon monoxide poisoning and delayed neurological sequelae: a potential neuroprotection bundle therapy
• control_conventional_without — Efficacy of hyperbaric oxygen therapy for diabetic foot ulcer, a systematic review and meta-analysis of controlled clinical trials